InSe Nanosheets for Efficient NIR-II-Responsive Drug Release

ACS Appl Mater Interfaces. 2019 Aug 7;11(31):27521-27528. doi: 10.1021/acsami.9b06170. Epub 2019 Jun 20.

Abstract

Near-infrared-II (NIR-II) biowindow is appealing from the perspectives of larger maximum permissible exposure in comparison with the near-infrared-I biowindow, so the NIR-II-responsive drug-delivery nanoplatform is highly desirable. In this work, two-dimensional InSe nanosheets (InSe NSs) are modified with poly(ethylene glycol) and evaluated as an effective NIR-II-responsive cancer treatment nanoplatform. The InSe NSs synthesized by liquid exfoliation exhibit prominent NIR-II-responsive photothermal conversion efficiency (39.5%) and photothermal stability. Moreover, the InSe NSs have a doxorubicin (DOX) loading capacity as high as 93.6%, along with excellent NIR-II-responsive DOX release characteristic. The superior synergistic chemo/photothermal effects have also been demonstrated by the in vitro experiments in killing cancer cells. In combination with good biocompatibility, the InSe NSs have great potential in therapeutic applications.

Keywords: InSe; NIR-II; cancer treatment; drug release; two-dimensional nanomaterials.

MeSH terms

  • Delayed-Action Preparations / chemistry
  • Delayed-Action Preparations / pharmacokinetics
  • Delayed-Action Preparations / pharmacology
  • Doxorubicin* / chemistry
  • Doxorubicin* / pharmacokinetics
  • Doxorubicin* / pharmacology
  • Humans
  • Hyperthermia, Induced*
  • MCF-7 Cells
  • Nanoparticles* / chemistry
  • Nanoparticles* / therapeutic use
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Phototherapy*

Substances

  • Delayed-Action Preparations
  • Doxorubicin